In vitro study on antioxidant and lipid-lowering activities of tobacco polysaccharides
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
In vitro study on antioxidant and lipid-lowering activities of tobacco polysaccharides ; volume:11 ; number:1 ; day:23 ; month:1 ; year:2024 ; pages:1-17 ; date:12.2024
Bioresources and Bioprocessing ; 11, Heft 1 (23.1.2024), 1-17, 12.2024
- Creator
-
Chang, Shuaishuai
Lei, Xiao
Xie, Qiang
Zhang, Mingjin
Zhang, Yuangai
Xi, Jiaxin
Duan, Jiyou
Ge, Jian
Nian, Fuzhao
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40643-024-00729-9
- URN
-
urn:nbn:de:101:1-2024040309224797094595
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chang, Shuaishuai
- Lei, Xiao
- Xie, Qiang
- Zhang, Mingjin
- Zhang, Yuangai
- Xi, Jiaxin
- Duan, Jiyou
- Ge, Jian
- Nian, Fuzhao
- SpringerLink (Online service)
Other Objects (12)
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Lipid-lowering properties of protein-rich mucuna product
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Nicotinic acid: a lipid-lowering agent with unrealized potential
Ezetimibe as lipid-lowering therapy for patients receiving HAART
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
Effects of Lipid-Lowering Drugs Upon Fasting-Induced Platelet Aggregation
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice
Initial non-adherence to lipid-lowering medication: a systematic literature review
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Lipid-lowering properties of protein-rich mucuna product
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Nicotinic acid: a lipid-lowering agent with unrealized potential
Ezetimibe as lipid-lowering therapy for patients receiving HAART
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
Effects of Lipid-Lowering Drugs Upon Fasting-Induced Platelet Aggregation
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice
Initial non-adherence to lipid-lowering medication: a systematic literature review
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Lipid-lowering properties of protein-rich mucuna product
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Nicotinic acid: a lipid-lowering agent with unrealized potential
Ezetimibe as lipid-lowering therapy for patients receiving HAART
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
Effects of Lipid-Lowering Drugs Upon Fasting-Induced Platelet Aggregation
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice
Initial non-adherence to lipid-lowering medication: a systematic literature review